Journal Information
Vol. 3. Issue 2.
Pages 91-92 (March - April 2007)
Vol. 3. Issue 2.
Pages 91-92 (March - April 2007)
Full text access
Use of Anti-Tumor Necrosis Factor Drugs in a Patient With Neurological Complications of Behçet's Disease
Visits
3152
Francisco José García Hernández, Celia Ocaña Medina, Rocío González León, Rocío Garrido Rasco, Julio Sánchez Román
Servicio de Medicina Interna, Unidad de Colagenosis, Hospitales Universitarios Virgen del Rocío, Sevilla, Spain
This item has received
Article information
Full text is only aviable in PDF
References
[1.]
L.P. Robertson, P. Hickling.
Treatment of recalcitrant orogenital ulceration of Behcet's syndrome with infliximab.
Rheumatology, 40 (2001), pp. 473-474
[2.]
P.P. Sfikakis, P.G. Theodossiadis, C.G. Katsiari, P. Kaklamanis, N.N. Markomichelakis.
Effect of infliximab on sight-threatening panuveitis in Behçet's disease.
Lancet, 358 (2001), pp. 295-296
[3.]
S. Muñoz Fernández, V. Hidalgo, J. Fernández Melón, A. Schlincker, E. Martín Mola.
Effect of infliximab on threatening panuveitis in Behçet's disease.
Lancet, 358 (2001), pp. 1644
[4.]
M.T. Kram, L.D. May, S. Goodman, S. Molinas.
Behcet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case.
Dis Colon Rectum, 46 (2003), pp. 118-121
[5.]
S.P.L. Travis, M. Czajkowski, D.P.B. McGovern, R.G.P. Watson, A.L. Bell.
Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody.
Gut, 49 (2001), pp. 725-728
[6.]
M. Melikoglu, I. Fresko, C. Mat, Y. Ozyazgan, F. Gogus, S. Yurdakul, et al.
Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.
J Rheumatol, 32 (2005), pp. 98-105
[7.]
G. Licata, A. Pinto, A. Tuttolomondo, A. Banco, F. Ciccia, A. Ferrante, et al.
Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome.
Ann Rheum Dis, 62 (2003), pp. 280-281
[8.]
H. Sarwar, H. McGrath Jr., L.R. Espinoza.
Successful treatment of long-standing neuro-Behçet's disease with infliximab.
J Rheumatol, 32 (2005), pp. 181-183
[9.]
F.J. García Hernández, C. Ocaña Medina, L. Mateos Romero, J. Sánchez Román, D. García Solís, J. Ruiz Franco-Baux, et al.
Utilidad de la SPECT cerebral con HMPAO-99mTc y de los test psicométricos en el diagnóstico de la afección neurológica de la enfermedad de Behçet.
Med Clin (Barc), 119 (2002), pp. 447-450
Copyright © 2007. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología